Gopal Kundu | |
|---|---|
| Born | (1959-11-02)2 November 1959 (age 66) Bataspur,West Bengal |
| Known for | Therapeutics;Biomarker (cell);Angiogenesis;Nanomedicine; |
| Awards | N-BIOS Prize,Shanti Swarup Bhatnagar Prize for Science and Technology |
| Scientific career | |
| Fields | Cancer |
| Institutions | National Centre for Cell Science |
Gopal Chandra Kundu (born 2 November 1959[1]) is an Indian cell and cancer biologist who worked as a scientist at the IndianNational Centre for Cell Science.[2] He is known for his contributions towards the understanding the mechanism of cancer progression inbreast,melanoma and other cancers and development of novel therapeutic targets and target-based therapy in cancers.[3]
An elected fellow of theIndian Academy of Sciences[4] and theNational Academy of Sciences, India,[5] he received theNational Bioscience Award for Career Development of theDepartment of Biotechnology in 2003.[6] He was awarded theShanti Swarup Bhatnagar Prize for Science and Technology, the highest Indian science awards, in 2004.[7]
Kundu studied chemistry and biology at theScottish Church College in Calcutta (nowKolkata), India. He obtained a B.Sc. with major in chemistry from theUniversity of Calcutta (affiliating university of SCC) in 1980. He completed M.Sc. in chemistry at the University of Calcutta in 1982.[1] He entered theBose Institute, Kolkata, for a doctoral course and earned his Ph.D. in 1989 inproteinbiochemistry In 1989, he went toCleveland Clinic Foundation, USA, as a post-doctoral fellow. For the next eight years, he worked as a research associate at theUniversity of Colorado (1990-1992), and then as a senior research associate at theUniversity of Wyoming (1992-1993) and theNational Institutes of Health, Bethesda (1993-1998). He became specialised incardiovascular biology,inflammation andimmunomodulation during that period. In 1998, he joined theNational Centre for Cell Science (NCCS),Pune, as Scientist-D.[8] At NCCS, he published his most important research papers coveringtumor biology, regulation of gene expression, cell signaling,angiogenesis, cancertherapeutics,biomarker studies for cancer detection, andnanomedicine.[9][10]
In 2019, Kundu retired from the government service at superannuation age. He was immediately appointed as director of research and development at theKalinga Institute of Industrial Technology (KIIT), a private university in Bhubaneswar, Odissa. He also holds professor positions in biotechnology at KIIT and in medicine and molecular research at Kalinga Institute of Medical Science.[11]
He serves as Editorial Board Member ofCurrent Molecular Medicine,Current Chemical Biology,Frontiers in Medicine,International Journal of Oncology,Molecular Medicine Reports,The Open Cancer Journal andAmerican Journal of Cancer Research. He is an associate editor ofMolecular Cancer andJournal of Cancer Metastasis and Treatment.[11]
Kundu is elected Fellow ofthe National Academy of Sciences, India (2003), theIndian Academy of Sciences (2006) andIndian National Science Academy (2023). He is member ofAmerican Society for Biochemistry and Molecular Biology andNew York Academy of Sciences. He was elected Fellow of theRoyal Society of Chemistry in 2023.[11]
In 1997, Kundu received Fellows Award for Research Excellence (FARE) from the US National Institute of Health of Health.[11] In 2003, Kundu received theNational Bioscience Award for Career Development from the Department of Biotechnology, government of India.[12] In 2004, he was awarded theShanti Swarup Bhatnagar Prize for Science and Technology in the field of biology,[13][12] the award of which is considered as the most prestigious in science under the government of India.[14] In 2007, theInternational Journal of Molecular Medicine from Greece gave him an "Internationalaward for an outstanding achievement in oncology". In 2013, he received the 7th National Grassroots Innovation Awards from the National Innovation Foundation for his works in cancer biology.[15]
A controversy erupted in the NCCS in 2006 when an anonymous mail alleged that Kundu and others might have misrepresented data in a paper published in theJournal of Biological Chemistry. The allegation was that they had rehashed the same set of data which they had published earlier.[16] An internal committee of the NCCS advised the authors to take back their paper, however an independent committee led byG. Padmanabhan, a former director of Indian Institute of Science, Bangalore, concluded that there was no manipulation in the data.[17] On 23 February 2007, theJournal of Biological Chemistry withdrew the paper amid allegations of data manipulation, although the authors maintained that the two papers used different set of data though similar experiments.
Authority control databases: Academics |
|---|